Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

Key Points

• The aim is to evaluate the safety of omitting prophylactic cranial irradiation in the treatment of childhood acute lymphoblastic leukemia (ALL).
• Risk-adjusted chemotherapy was utilized in the treatment protocol.
• ClinicalTrials.gov number NCT00137111 was referenced to indicate study registration.
• Omission of prophylactic cranial irradiation did not negatively impact treatment outcomes.
• Effective chemotherapy alone was sufficient to manage childhood ALL.